HRP20150507T1 - Novi antifungalni pripravak - Google Patents

Novi antifungalni pripravak Download PDF

Info

Publication number
HRP20150507T1
HRP20150507T1 HRP20150507TT HRP20150507T HRP20150507T1 HR P20150507 T1 HRP20150507 T1 HR P20150507T1 HR P20150507T T HRP20150507T T HR P20150507TT HR P20150507 T HRP20150507 T HR P20150507T HR P20150507 T1 HRP20150507 T1 HR P20150507T1
Authority
HR
Croatia
Prior art keywords
amount
composition according
present
preparation
acid
Prior art date
Application number
HRP20150507TT
Other languages
English (en)
Croatian (hr)
Inventor
Ake Lindahl
Original Assignee
Moberg Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45581892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20150507(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Moberg Pharma Ab filed Critical Moberg Pharma Ab
Publication of HRP20150507T1 publication Critical patent/HRP20150507T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HRP20150507TT 2011-02-11 2012-02-10 Novi antifungalni pripravak HRP20150507T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1150107 2011-02-11
PCT/EP2012/052327 WO2012107565A1 (en) 2011-02-11 2012-02-10 Novel antifungal composition
EP12703537.6A EP2672962B1 (en) 2011-02-11 2012-02-10 Novel antifungal composition

Publications (1)

Publication Number Publication Date
HRP20150507T1 true HRP20150507T1 (hr) 2015-06-19

Family

ID=45581892

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150507TT HRP20150507T1 (hr) 2011-02-11 2012-02-10 Novi antifungalni pripravak

Country Status (24)

Country Link
US (3) US8952070B2 (enExample)
EP (1) EP2672962B1 (enExample)
JP (1) JP5883886B2 (enExample)
KR (1) KR101647545B1 (enExample)
CN (2) CN103384518B (enExample)
AU (1) AU2012215383B2 (enExample)
BR (1) BR112013020456B1 (enExample)
CA (1) CA2826741C (enExample)
CY (1) CY1116275T1 (enExample)
DK (1) DK2672962T3 (enExample)
ES (1) ES2535827T3 (enExample)
HR (1) HRP20150507T1 (enExample)
IL (1) IL227765A (enExample)
ME (1) ME02152B (enExample)
MX (1) MX335945B (enExample)
PL (1) PL2672962T3 (enExample)
PT (1) PT2672962E (enExample)
RS (1) RS53982B1 (enExample)
RU (1) RU2587064C2 (enExample)
SG (1) SG192615A1 (enExample)
SI (1) SI2672962T1 (enExample)
SM (1) SMT201500154B (enExample)
WO (1) WO2012107565A1 (enExample)
ZA (1) ZA201305891B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX335945B (es) 2011-02-11 2016-01-04 Moberg Pharma Ab Composicion antifungica novedosa.
EP2728442B1 (en) * 2012-08-30 2016-06-08 Huawei Device Co., Ltd Method and device for controlling central processing unit
US10272054B2 (en) * 2015-10-07 2019-04-30 Exodos Life Sciences Lp Topical antifungal compositions
US10258560B1 (en) 2016-08-08 2019-04-16 Marlinz Pharma, LLC Composition for topical treatment of nail conditions
US10543276B2 (en) 2016-08-08 2020-01-28 Marlinz Pharma, LLC Topical compositions
EP3292758A1 (en) 2016-09-07 2018-03-14 Rottapharm S.p.A. Antimicrobial composition comprising a carboxylic acid and two diols
WO2019206389A1 (en) * 2018-04-27 2019-10-31 Unigroup Aps Kit of parts for nail fungus
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
EP4259116A1 (en) * 2020-12-08 2023-10-18 Moberg Pharma AB Treatment regimen for onchyomycosis using allylamine antifungal compositions

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
WO1999009997A1 (en) 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
AUPP146598A0 (en) * 1998-01-21 1998-02-12 Health And Hygiene International Pty Ltd Fruit and vegetable wash
DE19921794A1 (de) * 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
US8486426B2 (en) * 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
ATE384534T1 (de) * 2002-09-05 2008-02-15 Galderma Sa Lösung zur nagel-verwendung
JP5059408B2 (ja) * 2004-08-05 2012-10-24 久光製薬株式会社 爪用外用剤
US20060078599A1 (en) 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
CN1939539A (zh) * 2005-09-29 2007-04-04 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
EP1971324A1 (en) 2006-01-02 2008-09-24 TLT Medical Ltd Pharmaceutical composition for the treatment of nail diseases
US20070243222A1 (en) * 2006-02-03 2007-10-18 Carl Lawyer Fungicidal formulation and method of use
WO2007094999A2 (en) * 2006-02-13 2007-08-23 Stiefel Laboratories, Inc. Ungual antifungal compositions
US20080038219A1 (en) 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
WO2008152444A2 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
CA2676975A1 (en) * 2007-02-05 2008-08-14 Biophile Corporation, Ltd. Increased effectiveness of allylamine drug compounds
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
WO2009140215A2 (en) 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
PE20110642A1 (es) * 2008-07-23 2011-08-31 Tdt Ltd Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso
US8524258B2 (en) * 2008-12-22 2013-09-03 Johnson & Johnson Consumer Companies, Inc. Structured lotions
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
SG177750A1 (en) * 2009-08-13 2012-03-29 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail
JP5829217B2 (ja) * 2009-12-23 2015-12-09 ヌーボ リサーチ インコーポレイテッドNuvo Research Inc. 高浸透性テルビナフィン製剤
WO2012017371A1 (en) * 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it
MX335945B (es) 2011-02-11 2016-01-04 Moberg Pharma Ab Composicion antifungica novedosa.

Also Published As

Publication number Publication date
SMT201500154B (it) 2015-09-07
HK1190944A1 (en) 2014-07-18
KR101647545B1 (ko) 2016-08-10
RU2587064C2 (ru) 2016-06-10
PT2672962E (pt) 2015-05-25
CN103384518B (zh) 2018-10-26
AU2012215383B2 (en) 2016-06-09
IL227765A (en) 2016-09-29
ES2535827T3 (es) 2015-05-18
US20140031430A1 (en) 2014-01-30
CA2826741C (en) 2016-03-29
AU2012215383A1 (en) 2013-08-29
MX2013009245A (es) 2013-12-09
CY1116275T1 (el) 2017-02-08
RU2013136147A (ru) 2015-03-20
WO2012107565A1 (en) 2012-08-16
EP2672962B1 (en) 2015-03-25
US9561279B2 (en) 2017-02-07
US20150250878A1 (en) 2015-09-10
CN103384518A (zh) 2013-11-06
US8952070B2 (en) 2015-02-10
JP5883886B2 (ja) 2016-03-15
BR112013020456B1 (pt) 2020-01-21
SG192615A1 (en) 2013-09-30
DK2672962T3 (en) 2015-04-20
BR112013020456A2 (pt) 2016-10-18
EP2672962A1 (en) 2013-12-18
ZA201305891B (en) 2015-06-24
ME02152B (me) 2015-10-20
PL2672962T3 (pl) 2015-08-31
JP2014508146A (ja) 2014-04-03
CA2826741A1 (en) 2012-08-16
MX335945B (es) 2016-01-04
US20170258914A1 (en) 2017-09-14
IL227765A0 (en) 2013-09-30
CN109453150A (zh) 2019-03-12
RS53982B1 (sr) 2015-10-30
KR20140025341A (ko) 2014-03-04
SI2672962T1 (sl) 2015-06-30

Similar Documents

Publication Publication Date Title
HRP20150507T1 (hr) Novi antifungalni pripravak
JP2014508146A5 (enExample)
HRP20190824T1 (hr) Heterociklilamini kao inhibitori pi3k
ME03347B (me) PARAZITICIDNE KOMPOZICIJE KOJE SADRŽE IZOKSAZOLINSKO AKTIVNO SREDSTVO, POSTUPCI l UPOTREBE POVEZANE SA NJIMA
IN2012DN05233A (enExample)
WO2012082580A3 (en) Fungicidal azocyclic amides
MX382421B (es) Mezclas fungicidas ternarias.
BR112012017382A2 (pt) compostos inibidores de viroses flaviviridae, uso dos mesmos e composição farmacêutica
EP2714685A4 (en) COMPOSITIONS CONTAINING DOLASTATIN DERIVATIVES COMPOSED WITH NON-NATURAL AMINO ACIDS, AND METHODS THEREFOR, AND APPLICATIONS THEREOF
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
CL2014003475A1 (es) Forma c cristalina de acido obeticolico; proceso de preparacion de la forma 1 de acido obeticolico a partir de la forma c cristalina; composicion farmaceutica que comprende a una forma cristalina de acido obeticolico, util para el tratamiento o prevencion de una enfermedad hepatica colestasica, hepatopatia alcoholica y enfermedades cardiovasculares tal como aterosclerosis, entre otras.
CL2013000567A1 (es) Molecula derivada de n-piridin-tiadiazol amida; composicion que lo comprende; proceso que comprende aplicar dicha molécula en una planta transgénica; uso para tratar endoparásitos, ectoparásitos o ambos.
WO2007122581A3 (en) Compositions and kits of phenylephrine
BR112013023103A2 (pt) composições de herbicidas e protetores
BR112012007322A2 (pt) composto de 2-piridona usados como inibidores de neutrófilo elastase
MX2011009093A (es) Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas.
CR20130081A (es) Composición para el tratamiento de plantas y métodos para su uso
NZ609633A (en) Fungicidal penflufen mixtures
BR112015008717A2 (pt) composto, composição farmacêutica, método de tratar diabetes do tipo ii, uso do composto de fórmula (i), medicação para o tratamento de diabetes do tipo ii
UY33014A (es) Nuevos compuestos de diazinil-pirazolilo
BR112014002958A2 (pt) "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso".
HRP20140413T1 (hr) Spla2 hidrolizirajuä†i liposomi s poboljšanim svojstvima pohranjivanja
DOP2010000329A (es) Inhibidores de la renina
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
PH12012501815A1 (en) Curable composition